尿毒症

niào dú zhèng
  • uremia;uraemia;urinaemia;toxuria
尿毒症尿毒症
尿毒症[niào dú zhèng]
  1. 维持性血液透析尿毒症病人瘙痒症的治疗与护理

    Treatment and nursing care of pruritus in toxuria patients undergoing maintenance hemodialysis

  2. 尤其以I型糖尿病病人为主。若I型糖尿病病程过20年,10%会有肾病,最终会发展为终末期肾病即尿毒症。

    In type I diabetic patients who have a disease progress over 20 years , 10 % would have nephropathy which would progress to terminal conditions such as toxuria .

  3. 尿毒症脑病颅脑CT与MRI检查价值的探讨

    Value of the CT and MRI Examination in the Uremic Encephalopathy

  4. CD检测评价尿毒症合并心力衰竭时血液动力学改变分析

    Analysis of hemodynamic changes in uremia patients with heart failure by using circulation dynamics detection

  5. 尿毒症患者血清中Zn,Cu,Al的代谢

    Preliminary study to metabolism of microelements zn , cu and Al in the serum of uraemia patients

  6. 小剂量1,25(OH)2D3口服冲击治疗尿毒症患者继发性甲状旁腺功能亢进

    Pulse therapy of low dose oral 1,25 ( OH ) 2D 3 in uremic patients with second hyperparathyroidism

  7. 目的探讨应用On-line血液透析滤过治疗慢性肾衰尿毒症患者的临床效果及护理措施。

    Objective To explore the clinical effect and nursing methods on applying On-line Hemodiafiltration to treat uremia of chronic renal failure .

  8. 目的探讨Rh阴性尿毒症患者接受Rh阳性供肾移植的可行性及疗效。

    Objective To investigate the effectiveness of Rh-negative patients receiving Rh-positive renal grafts .

  9. 结论慢性肾炎及尿毒症患者白细胞ER的结合容量明显升高;

    Conclusion The Bmax of ER increased in chronic nephritis and uremia and the Bmax of AR decreased in uremia .

  10. 尿毒症患者合并心力衰竭血清TNF-α、NO与ET水平的变化及临床意义

    The change and clinical significance of TNF - α, NO and ET level in patients with uremia complicated with heart failure

  11. 目的探讨改良腹膜平衡试验(改良PET)在尿毒症患者腹膜透析中的应用。

    Objective : To investigate the role of modified peritoneal equilibrium test ( modified PET ) in peritoneal dialysis ( PD ) patients .

  12. 尿毒症血液透析患者血浆血小板相关抗体IgG的变化及其对出血并发症的影响

    Change in plasma antiplatelet associated antibody and its effect on the complications of bleeding in patients with uremia during hemodialysis

  13. 结论尿毒症患者中性粒细胞功能受损,接受EPO治疗后,其功能得到改善。

    Conclusion Depressed functions of neutrophils in uremic patients were improved by EPO treatment .

  14. 尿毒症患者血压、血清NO和ET水平均明显高于正常老年人;

    The BP and the levels of serum NO and ET in uremic patients were distinctly higher than those in normal old people .

  15. 结论PTH是影响尿毒症患者营养状况的重要尿毒素。

    Conclusion PTH can impact nutritional status of uraemia patients ;

  16. 结论尿毒症状态可刺激细胞因子的基因表达及合成释放,透析治疗可不同程度增加细胞因子mRNA表达,腹膜透析对外周血单个核细胞的刺激作用低于血透。

    Conclusion Uremia toxin could stimulate PBMC to express cytokine gene and release cytokines . Dialysis therapy , especially for hemodialysis , enhance cytokine mRNA expression .

  17. 目的探讨血液透析(HD)串联血液灌流(HP)治疗尿毒症瘙痒的疗效。

    Objective To investigate the therapeutic effects of hemodialysis ( HD ) with hemoperfusion in the treatment of Uremic pruritus .

  18. 尿毒症血清对外周血单个核细胞IL-18表达及分泌水平的影响

    Effects of Uremic Serum on Secretion and Expression of IL-18 in Peripheral Blood Mononuclear Cells

  19. 目的:探讨治疗糖尿病肾病(DN)尿毒症较理想的透析方法。

    Objective : To asses the effect of different dialysis methods in uremia patients with diabetic nephropathy .

  20. 收集尿毒症患者近一周的PTH检验结果。

    Collect the PTH testing results of uremia patients .

  21. ox-LDL在尿毒症患者血管壁上的沉积及其对血管重塑的影响

    Deposition of ox-LDL on uremic vessel wall and its influence on vascular remodeling

  22. Tei指数评价尿毒症患者左心功能

    Tei index for assessing left ventricular function in patients with uremia

  23. 结论:前稀释高容量联机HF清除较大分子量尿毒症毒素明显优于低通量HD。

    Conclusion Pre-dilution high volume on-line hemofiltration are markedly superior to low permeable hemodialysis in the clearance of larger uremic toxin molecules .

  24. 结论:尿毒症患者存在继发性红细胞免疫功能低下,系外周血循环免疫复合物(CIC)升高所致。

    Conclusions Uremic patients had acquired RBC immunity function reduction , as the CIC in the circulatory system increased .

  25. 血小板粘附率和膜糖蛋白Ib含量测定在尿毒症出血症状中的意义

    The significance in determination of platelet adhesion rate and membrane glycoprotein Ib concentration in uremic hemorrhage

  26. 本文则在此基础上,详细研究了X3树脂对尿毒症患者血浆中分子物质的吸附性能及其血液相容性。

    Was chosen to be the effective adsorbent of the MMS . The removal of MMS from uremic plasma by X3 resin and the blood compatibility of the X3 resin were studied .

  27. CRRT治疗老年尿毒症低钾血症并发心律失常临床观察及分析

    CRRT for arhythmia caused by hypokaliemia in aged uremia

  28. 组织多普勒超声Tei指数评价尿毒症患者右室功能

    Estimation of global function of right ventricle in uremic patients by tissue Doppler Tei index

  29. 结论IL-6、CRP是尿毒症血液透析病人炎症反应较好的预测指标,并且在营养不良和贫血中起重要作用。

    Conclusion CRP and IL-6 are the better predictive markers of inflammation and play an important role in malnutrition and anemia in patients undergoing hemodialysis .

  30. 目的探讨尿毒症维持性血液透析(MHD)患者血浆选择素水平变化。

    Objective To investigate the changes of plasma selectin level in the uremic patients with maintenance hemodialysis ( MHD ) .